Members of the nuclear factor (NF)-κB/Rel family transcription factors are induced during thymic selection and in mature T lymphocytes after ligation of the T cell antigen receptor (TCR). Despite these findings, disruption of individual NF-κB/Rel genes has revealed no intrinsic defect in the development of mature T cells, perhaps reflecting functional redundancy. To circumvent this possibility, the T cell lineage was targeted to express a trans-dominant form of IκBα that constitutively represses the activity of multiple NF-κB/Rel proteins. Transgenic cells expressing this inhibitor exhibit a significant proliferative defect, which is not reversed by the addition of exogenous interleukin-2. Moreover, mitogenic stimulation of splenocytes leads to increased apoptosis of transgenic T cells as compared with controls. In addition to deregulated T cell growth and survival, transgene expression impairs the development of normal T cell populations as evidenced by diminished numbers of TCRhi CD8 single-positive thymocytes. This defect was significantly amplified in the periphery and was accompanied by a decrease in CD4+ T cells. Taken together, these in vivo findings indicate that the NF-κB/Rel signaling pathway contains compensatory components that are essential for the establishment of normal T cell subsets.
Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB
Address correspondence to Mark Boothby or Dean Ballard, Department of Microbiology and Immunology, Vanderbilt University Medical School, Nashville, Tennessee 37232-2363.
The authors acknowledge A. Cherrington and W. Armistead for technical assistance; J. Wright and C. Pettipher (Vanderbilt Cancer Center Transgenic Core) for DNA microinjections; A. Lackey (Cytometry Associates, Brentwood, TN) and J. Price (Vanderbilt Cancer Center Core) for expert flow cytometry analyses; L. Glimcher, E. Oltz, T. Aune, G. Miller, D. Perkins, T. Laufer, J. Chen, L. Van Kaer, E. Robey, D. Kioussis, L. Kelley, and P. Fink for helpful discussions; and E. Vance for help with manuscript preparation. D.W. Ballard is an investigator of the Howard Hughes Medical Institute (HHMI). Supported by National Institutes of Health grant AI-33839 and the Howard Hughes Medical Institute (D.C. Scherer, J.A. Brockman, D.W. Ballard), and by National Institutes of Health grant AI-36997, GM-42550, and the Leukemia Society of America (A.L. Mora, M.R. Boothby).
1Abbreviations used in this paper: BrdU, 5-bromo-2′-deoxyuridine; κB-pd, κB enhancer sequences based on the IL-2R α promoter; NF-κB, nuclear factor-κB; SP, single positive.
Mark R. Boothby, Ana L. Mora, David C. Scherer, Jeffrey A. Brockman, Dean W. Ballard; Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB. J Exp Med 2 June 1997; 185 (11): 1897–1907. doi: https://doi.org/10.1084/jem.185.11.1897
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement